Lv44
510 积分 2024-03-19 加入
De novo design of a peptide modulator to reverse sodium channel dysfunction linked to cardiac arrhythmias and epilepsy
1天前
已完结
The rise of China’s pharmaceutical industry from 2015–2024: a decade of innovation
2天前
已完结
AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
22天前
已完结
Anti-TL1A antibody, afimkibart, in moderately-to-severely active ulcerative colitis (TUSCANY-2): a multicentre, double-blind, treat-through, multi-dose, randomised, placebo-controlled, phase 2b trial
24天前
已完结
Upgrading therapeutic ambitions and treatment outcomes
27天前
已完结
Inflammatory bowel disease: classifying global regions by epidemiological stage
27天前
已完结
Mechanisms of mucosal healing: treating inflammatory bowel disease without immunosuppression?
27天前
已完结
Deciphering the different phases of preclinical inflammatory bowel disease
27天前
已完结
Inflammatory Bowel Disease: Pathophysiology, Treatment, and Disease Modeling
28天前
已完结
Autoantibodies in systemic lupus erythematosus: From immunopathology to therapeutic target
1个月前
已完结
皖公网安备34019202002308
